A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver.
Prednisone was granted FDA approval on 21 February 1955.
Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.
"Mikaelyan" Surgery Institute, Yerevan, Armenia
"Armenia" Republican Medical Center, Yerevan, Armenia
Erebouni Medical Center, Yerevan, Armenia
Rogel Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
UC San Diego Moores Cancer Center, La Jolla, California, United States
Keck Medicine of USC Koreatown, Los Angeles, California, United States
Los Angeles General Medical Center, Los Angeles, California, United States
Xing Xiaojing, Shenyang, Liaoning, China
Cardiff and vale University LHB, Cardiff, United Kingdom
Belfast Health & Social Care Trust, Belfast, United Kingdom
NHS Grampian, Aberdeen, United Kingdom
United Medical Group, Miami, Florida, United States
Orlando Health Cancer Institute, Orlando, Florida, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Magna Graecia University of Catanzaro, Catanzaro, CZ, Italy
Uls Coimbra - Hosp. Univ. Coimbra, Coimbra, Portugal
Inselspital Universitatsspital Bern, Bern, Switzerland
Retinal Research Institute, Phoenix, Arizona, United States
ASST Spedali Civili di Brescia, Brescia, Italy
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.